Profiling of Natural Killer Interactions With Cancer Cells Using Mass Cytometry

Lab Invest. 2023 Aug;103(8):100174. doi: 10.1016/j.labinv.2023.100174. Epub 2023 May 9.

Abstract

We developed a comprehensive method for functional assessment of the changes in immune populations and killing activity of peripheral blood mononuclear cells after cocultures with cancer cells using mass cytometry. In this study, a 43-marker mass cytometry panel was applied to a coculture of immune cells from healthy donors' peripheral blood mononuclear cells with diverse cancer cell lines. DNA content combined with classical CD45 surface staining was used as gating parameters for cocultures of immune cells (CD45high/DNAlow) with hematological (CD45low/DNAhigh) and solid cancer cell lines (CD45neg/DNAhigh). This strategy allows for universal discrimination of cancer cells from immune populations without the need for a specific cancer cell marker and simultaneous assessment of phenotypical changes in both populations. The use of mass cytometry allows for simultaneous detection of changes in natural killer, natural killer T cell, and T cell phenotypes and degranulation of immune populations upon target recognition, analysis of target cells for cytotoxic protein granzyme B content, and cancer cell death. These findings have broad applicability in research and clinical settings with the aim to phenotype and assess functional changes following not only NK-cancer cell interactions but also the effect of those interactions on other immune populations.

Keywords: NK cells; cytotoxicity; granzyme B transfer; innate immunity; mass cytometry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coculture Techniques
  • Cytotoxicity, Immunologic*
  • Flow Cytometry
  • Killer Cells, Natural
  • Leukocytes, Mononuclear
  • Neoplasms* / metabolism
  • T-Lymphocytes